Medical Devices and Mass Tort Marketing for Law Firms
Medical Mass Tort Litigation Is Changing, and You Need to Be Proactive
In the past, mass tort lawyers would wait for a medical device recall or product withdrawal before initiating litigation. Times have changed. Today, cutting-edge mass tort firms track data from the federal government and social media, looking for potentially dangerous products and marketing to victims before there’s a regulatory action or voluntary recall.
As an injury lawyer, you need to take a proactive approach, exploring causes of action and nurturing leads early on. At LaFleur, we help law firms reach and educate potential clients who have been harmed by medical devices. Our mass tort marketing services include:
- Paid advertising campaigns, including PPC and display ad campaigns
- Social media advertising and posts
- Email drip campaigns
- Ebooks and other lead-generating content
- Mass tort newsletters focused on lead nurturing
- Landing page design
- Marketing automation, including phone and text campaigns
- Intake optimization
- Video production and editing
- Public and media relations management
Unlike the big-box advertising agencies, we build customized advertising campaigns and create unique content that builds trust, informs readers, and generates trackable leads. We can also help you audit your current advertising campaigns if you’re concerned about compliance with state and federal regulations.
Dangerous Medical Devices Are a Leading Cause of Multidistrict Litigation (MDL)
Due to the combination of our aging population and medical advances, a growing number of Americans rely on medical devices every day. According to the American Academy of Orthopaedic Surgeons, between 2018 and 2030, first-time total hip replacement rates will grow by 171%, and revision surgeries will increase by 142%. That means millions of people will need hip implants.
Researchers also anticipate significant increases in the use of implantable defibrillators, pacemakers, insulin pumps, and other medical devices. And device manufacturers are continually changing their product lines and introducing new technologies. (Did you know that insulin pumps have one of the highest rates of malfunction, according to recent FDA database data?)
Unfortunately, not all devices are safe and well-designed. After pharmaceutical lawsuits, medical device claims are the top focus of most mass tort lawyers. While there’s already well-known pending litigation involving hip implants, hernia and pelvic mesh, and IVC filters, you should also broaden your focus to look for developing issues.
For example, the dramatic increase in connected, “smart” medical devices will most likely cause a spike in litigation. These cases will stem from cybersecurity issues that occur because medical device manufacturers fail to protect users from hacking and design errors. Mass tort claims may also arise when manufacturers and retailers mislead consumers about the capabilities of connected, wearable devices that allegedly monitor their heart rates and other health data.
To keep up, law firms need sophisticated marketing partners who can help them identify potential causes of action, educate the public, and inform potential clients about their rights and options. Unfortunately, too many marketing agencies and law firms passively wait for the big firms and government agencies to move first.
Fact-Based Mass Tort Advertising That Targets Your Ideal Clients
At LaFleur, we don’t engage in fear-based, reactive marketing. Our team includes capable researchers and CDC-certified health literacy writers who identify mass tort trends early on and deliver accurate and carefully crafted messaging. These messages educate, inform, and empower the victims of medical device company negligence while also educating them about your firm’s brand and unique strengths.
LaFleur: Discover the Benefits of Customized Mass Tort Marketing
If you’re ready for a refreshing, personalized approach to your medical device mass tort marketing, contact LaFleur today. We’ll audit your current strategies and find the most efficient avenues to get you the valuable leads and cases your firm needs to grow.
MDL statistics report: Distribution of pending MDL dockets by actions pending. (2020, April 15). United States Panel on Multidistrict Litigation. Retrieved from https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-April-15-2020.pdf
Mikulic, M. (2019, October 9). Global number of pacemakers in 2016 and a forecast for 2023 (in million units). Statista. Retrieved from https://www.statista.com/statistics/800794/pacemakers-market-volume-in-units-worldwide/
Mohr, H., & Weiss, M. (2018, November 27). Insulin pumps have most reported problems in FDA database. AP. Retrieved from https://apnews.com/2f782225f9d74bb9941933b12f8e96f6
Projected volume of primary and revision total joint replacement in the U.S. 2030 to 2060. (2018, March 6). American Academy of Orthopaedic Surgeons. Retrieved from https://aaos-annualmeeting-presskit.org/2018/research-news/sloan_tjr/
Umpierrez, G., & Klonoff, D. (2018, August). Diabetes technology update: Use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. Retrieved from https://care.diabetesjournals.org/content/41/8/1579